Spinal Cord Stimulation (SCS) Dosing Study

NCT03284411 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-15

Study results available
· View outcomes & findings →

Summary

This study characterized the effects of amplitude on subject satisfaction and pain relief in subjects being treated by SCS.

Conditions

Interventions

DEVICE

Spinal Cord Stimulation

Programming

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2019-03-15
Completion
2019-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284411 on ClinicalTrials.gov